The agenda for this call will include a review of the Q4 financial result, as well as Q1 and full year guidance from Sam, and update on the CRM business from Jim, a review of the cardiovascular and other business and update on our quality initiatives from Paul, and the CEO perspective from Jim followed by a question-and-answer session.